Robert Waltermire
Fortune : 3 M $ au 31/07/2026
Fortune : 3 M $ au 31/07/2026
Robert Waltermire is currently the Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals, Inc. He previously worked at Venatorx Pharmaceuticals, Inc. as the Senior Vice President-CMC from 1988 to 2020.
Waltermire completed his undergraduate degree at Franklin & Marshall College in 1984 and obtained his doctorate from the University of Maryland in 1988.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/03/2025 | 5 789 ( 0,03% ) | 3 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/08/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel anti-infectives to treat multi-drug-resistant bacterial and viral infections | Corporate Officer/Principal | 01/01/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel anti-infectives to treat multi-drug-resistant bacterial and viral infections | Health Technology |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national